These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1058 related items for PubMed ID: 29501581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling.
    Liu QQ, Chen J, Ma T, Huang W, Lu CH.
    Sci Rep; 2024 Apr 24; 14(1):9425. PubMed ID: 38658618
    [Abstract] [Full Text] [Related]

  • 3. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
    Liu C, Yuan X, Tao L, Cheng Z, Dai X, Sheng X, Xue D.
    BMC Complement Altern Med; 2015 Jun 30; 15():201. PubMed ID: 26122378
    [Abstract] [Full Text] [Related]

  • 4. Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling.
    Hu Z, You P, Xiong S, Gao J, Tang Y, Ye X, Xia Y, Zhang D, Liu Y.
    Biomed Pharmacother; 2017 Nov 30; 95():11-17. PubMed ID: 28826091
    [Abstract] [Full Text] [Related]

  • 5. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
    Li X, Jin Q, Yao Q, Xu B, Li Z, Tu C.
    Toxicol Lett; 2016 Nov 02; 261():1-12. PubMed ID: 27601294
    [Abstract] [Full Text] [Related]

  • 6. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
    Zhang C, Liu XQ, Sun HN, Meng XM, Bao YW, Zhang HP, Pan FM, Zhang C.
    Int Immunopharmacol; 2018 Oct 02; 63():183-190. PubMed ID: 30098497
    [Abstract] [Full Text] [Related]

  • 7. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X.
    J Ethnopharmacol; 2018 Jan 10; 210():232-241. PubMed ID: 28864168
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX, Yao Y, Bu FT, Chen Y, Wu YT, Yang Y, Chen X, Zhu Y, Wang Q, Pan XY, Meng XM, Huang C, Li J.
    Mol Immunol; 2019 Mar 10; 107():29-40. PubMed ID: 30639476
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
    Wang R, Zhang H, Wang Y, Song F, Yuan Y.
    Int Immunopharmacol; 2017 Jun 10; 47():126-133. PubMed ID: 28391159
    [Abstract] [Full Text] [Related]

  • 13. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ, Kim DH, Kim SJ, Kim J, Jeong SI, Chung CH, Yu KY, Kim SY.
    Life Sci; 2014 Jul 17; 108(2):94-103. PubMed ID: 24880074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH, Jang EJ, Seo HL, Ku SK, Lee JR, Shin SS, Park SD, Kim SC, Kim YW.
    Chem Biol Interact; 2014 Dec 05; 224():58-67. PubMed ID: 25451574
    [Abstract] [Full Text] [Related]

  • 17. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways.
    Shi L, Zhou L, Han M, Zhang Y, Zhang Y, Yuan XX, Lu HP, Wang Y, Yang XL, Liu C, Wang J, Liang P, Liu SA, Liu XJ, Cheng J, Lin SM.
    World J Gastroenterol; 2023 May 14; 29(18):2798-2817. PubMed ID: 37274069
    [Abstract] [Full Text] [Related]

  • 18. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
    França MER, Rocha SWS, Oliveira WH, Santos LA, de Oliveira AGV, Barbosa KPS, Nunes AKS, Rodrigues GB, Lós DB, Peixoto CA.
    Inflammopharmacology; 2018 Apr 14; 26(2):599-609. PubMed ID: 28409388
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F, Lu Z, Huang K, Wang X, Xu Z, Chen B, Dong P, Zheng J.
    Oncotarget; 2016 Jan 05; 7(1):81-93. PubMed ID: 26637809
    [Abstract] [Full Text] [Related]

  • 20. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N, Perumal M, Halagowder D, Sivasithamparam N.
    Biochimie; 2017 Sep 05; 140():10-19. PubMed ID: 28552397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.